Skip to content
Disclosery

EXANE DERIVATIVES: AVGO position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on AVGO, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 421 AVGO shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 421 shares
    Change vs previous 13F -2,390 shares

    0.12% of the 13F portfolio, value $204,504.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 2,811 shares
    Change vs previous 13F -551 shares

    0.5% of the 13F portfolio, value $1,769,921.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 3,362 shares
    Change vs previous 13F +388 shares

    0.54% of the 13F portfolio, value $2,237,027.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 2,974 shares
    Change vs previous 13F +313 shares

    0.36% of the 13F portfolio, value $1,442,130.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 2,661 shares
    Change vs previous 13F +2,579 shares

    0.3% of the 13F portfolio, value $1,287,921.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 82 shares
    Change vs previous 13F -1,216 shares

    0.01% of the 13F portfolio, value $38,018.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 1,298 shares
    Change vs previous 13F +834 shares

    0.17% of the 13F portfolio, value $568,303.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 464 shares
    Change vs previous 13F not available

    0.06% of the 13F portfolio, value $169,035.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).